Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro.
Huang. Tonglie T; Zhang. Kuo K; Sun. Lijuan L; Xue. Xiaochang X; Zhang. Cun C; Shu. Zhen Z; Mu. Nan N; Gu. Jintao J; Zhang. Wangqian W; Wang. Yukun Y; Zhang. Yingqi Y; Zhang. Wei W
Key Findings
- Topical BPC‑157 sped up wound closure and improved tissue quality in an alkali‑burn rat model.
- The peptide boosted VEGF‑A levels and activated ERK1/2 signaling, promoting blood‑vessel growth.
- In cultured human endothelial cells, BPC‑157 increased proliferation, migration, and tube formation.
Practical Outcomes
- For biohackers, BPC‑157 looks promising as a topical aid for faster skin repair after burns or injuries, but the evidence is limited to animals and cell cultures. No human dosing or safety data are provided, so anyone considering it should proceed cautiously, start with low concentrations, and monitor for adverse reactions. More clinical research is needed before it can be recommended as a standard wound‑healing protocol.
Summary
In rats with a harsh alkaline skin burn, applying BPC‑157 directly to the wound helped the skin close faster. The treated wounds showed better new tissue growth, thicker skin layers, more collagen, and more blood‑vessel formation. In lab dishes, BPC‑157 also made human blood‑vessel cells multiply, move, and form tiny tube‑like structures, likely by turning on a growth‑signal pathway called ERK1/2.
Abstract
Chemical burns take up a high proportion of burns admissions and can penetrate deep into tissues. Various reagents have been applied in the treatment of skin chemical burns; however, no optimal reagent for skin chemical burns currently exists. The present study investigated the effect of topical body protective compound (BPC)-157 treatment on skin wound healing, using an alkali burn rat model. Topical treatment with BPC-157 was shown to accelerate wound closure following an alkali burn. Histological examination of skin sections with hematoxylin-eosin and Masson staining showed better granulation tissue formation, reepithelialization, dermal remodeling, and a higher extent of collagen deposition when compared to the model control group on the 18th day postwounding. BPC-157 could promote vascular endothelial growth factor expression in wounded skin tissues. Furthermore, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and cell cycle analysis demonstrated that BPC-157 enhanced the proliferation of human umbilical vein endothelial cells (HUVECs). Transwell assay and wound healing assay showed that BPC-157 significantly promoted migration of HUVECs. We also observed that BPC-157 upregulated the expression of VEGF-a and accelerated vascular tube formation in vitro. Moreover, further studies suggested that BPC-157 regulated the phosphorylation level of extracellular signal-regulated kinases 1 and 2 (ERK1/2) as well as its downstream targets, including c-Fos, c-Jun, and Egr-1, which are key molecules involved in cell growth, migration, and angiogenesis. Altogether, our results indicated that BPC-157 treatment may accelerate wound healing in a model of alkali burn-induced skin injury. The therapeutic mechanism may be associated with accelerated granulation tissue formation, reepithelialization, dermal remodeling, and collagen deposition through ERK1/2 signaling pathway.
Study Information
pubmed
2015
2015-04-30T00:00:00.000Z
10.2147/dddt.s82030